HAII7 gene increased the multidrug resistance of K562 cells in vitro: An investigation to the function of a novel gene related to drug resistance

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Guo, Yuxia ^a   Zheng, Gaihuan ^a   Jin, Xianqing ^a   Xu, Youhua ^a   Luo, Qing ^a   Liu, Xiaomei ^a   Zhao, Zhenzhen ^a   Chen, Yong ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CYCLOPHOSPHAMIDE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; HA117 PROTEIN; MESSENGER RNA; MITOMYCIN; MULTIDRUG RESISTANCE PROTEIN; TETRAZOLIUM; UNCLASSIFIED DRUG; VINCRISTINE; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER GROWTH; CANCER RESISTANCE; CELL ASSAY; CHEMOSENSITIVITY; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; MESSENGER RNA SYNTHESIS; MOLECULAR CLONING; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ADENOVIRUS; CELL STRAIN K 562; DRUG EFFECT; DRUG RESISTANCE; ENZYME SPECIFICITY; GENE EXPRESSION REGULATION; GENETICS;

ADENOVIRIDAE; ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; K562 CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUBSTRATE SPECIFICITY;

EID: 67149093664     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-63     Document Type: Article

References (19)

1. Cellular mechanisms of multidrug resistance of tumor cells. EH Estey, Biochemistry (Mosc) 2000 65 1 95 106 10702644
2. Molecular cancer therapeutics: recent progress and targets in drug resistance. D Frame, Intern Med 2003 42 3 237 43 10.2169/internalmedicine.42.237 12705787
3. Analysis and characterization of differential gene expression during rapid trophoblastic elongation in the pig using suppression subtractive hybridization. JW Ross MD Ashworth AG Hurst JR Malayer RD Geisert, Reprod Biol Endocrinol 2003 1 23 12646053 10.1186/1477-7827-1-23
4. Profiling analysis of differential gene expression between hematogenous and peritoneal metastatic sublines of human pancreatic cancer using a DNA chip. F Hata H Nishimori T Yasoshima H Tanaka K Ohno Y Yanai E Ezoe K Kamiguchi H Isomura R Denno N Sato K Hirata, J Exp Clin Cancer Res 2004 23 3 513 20 15595644
5. Screening and cloning of multi-drug resistant genes in HL-60/MDR cells. GH Zheng JR Fu YH Xu XQ Jin WL Liu JF Zhou, Leuk Res 2009 33 8 1120 1123 19135252
6. A simplified system for generating recombinant adenoviruses. TC He S Zhou LT da Costa J Yu KW Kinzler B Vogelstein, Proc Nail Acad Sci USA 1998 95 2509 2514 10.1073/pnas.95.5.2509
7. Mechanism of apoptotic effects induced selectively by ursodeoxycholic acid on human hepatoma cell lines. H Liu CY Qin GQ Han, World J Gastroenterol 2007 13 1652 1658 17461466 (Pubitemid 46711334)
8. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. ME Huang YC Ye SR Chen, Blood 1988 72 567 572 3165295
9. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy. GB Zhou J Zhang ZY Wang SJ Chen Z Chen, Philos Trans R Soc Lond B Biol Sci 2007 362 959 971 17317642 10.1098/rstb.2007.2026
10. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). RP Warrell Jr SR Frankel WH Miller DA Scheinberg LM Itn WN Hittelman R Vyas A Andreff A Tafudi A Jakubowski J Gabrilove M Gordon E Dmitrovsky, N Engl J Med 1991 324 1385 1393 1850498
11. A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. ZX Chen YQ Xue R Zhang RF Tao XM Xia C Li W Wane WY Zu XZ Yao BJ Ling, Blood 1991 78 1413 1419 1884013
12. Retinoic acid resistance in acute promyelocytic leukemia. RE Gallagher, Leukemia 2002 16 1940 1958 10.1038/sj.leu.2402719 12357346
13. Current treatment of acute promyelocytic leukemia. F Lo Coco E Ammatuna MA Sanz, Haematologica 2007 92 3 289 91 10.3324/haematol.11226 17339175
14. MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML. M Heuser B Argiropoulos F Kuchenbauer E Yung J Piper S Fung RF Schlenk K Dohner T Hinrichsen C Rudolph A Schambach C Baum B Schlegelberger H Dohner A Ganser RK Humphries, Blood 2007 110 5 1639 1647 10.1182/blood-2007-03-080523 17494859
15. Translocations of the RARalpha gene in acute promyelocytic leukemia. A Zelent F Guidez A Melnick, Oncogene 2001 20 49 7186 7203 10.1038/sj.onc.1204766 11704847
16. The possibility of simvastatin as a chemotherapeutic agent for all-trans retinoic acid-resistant promyelocytic leukemia. N Tomiyama S Matzno C Kitada E Nishiguchi N Okamura K Matsuyama, Biol Pharm Bull 2008 31 3 369 74 10.1248/bpb.31.369 18310894
17. Effect of all-trans retinoic acid on drug sensitivity and expression of survivin in LoVo cells. HB Wei BG Hu XY Han ZH Zheng B Wei JL Huang, Chin Med J (Engl) 2008 121 331 335 18304466
18. Construction of recombinant adenovirus co-expression vector carrying the human transforming growth factor-beta1 and vascular endothelial growth factor genes and its effect on anterior cruciate ligament fibroblasts. X Fu JY Zhang ZB Mao CL Yu, Chin Med J (Engl) 2008 121 1426 1432 18959121
19. Current advances and future challenges in Adenoviral vector biology and targeting. SK Campos MA Barry, Curr Gene Ther 2007 7 189 204 17584037 10.2174/156652307780859062